Navigation Links
Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
Date:3/19/2008

CALGARY, March 19 /PRNewswire-FirstCall/ - Notification of Year End 2007 Earnings Webcast and Conference Call event:

Response Biomedical Corp. (TSX: RBM)

Year End 2007 Earnings Webcast and Conference Call

March 31, 2008, 5:30 PM ET

To listen to this Webcast and Conference Call event, please enter http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2167880 in your web browser.

To participate in the live conference call please dial into either (604) 677-8677 or (800) 733-7571.

For a complete listing of upcoming and archived webcasts available through CNW Group, please visit our events calendar at http://www.newswire.ca/en/webcast/index.cgi. CNW's webcast of earnings calls is consistent with Market Regulation Services Inc. (RS) objectives of providing investors with material information broadly and quickly.

CONTACT: Response Biomedical Contacts: Bill Wickson, Manager, Investor Relations, Response Biomedical Corporation, Tel (604) 456-6073, Email: bwickson@responsebio.com; Brian Korb, Vice President, The Trout Group LLC, Tel: (646) 378-2923, Email: bkorb@troutgroup.com


'/>"/>
SOURCE CNW Webcasts
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Study identifies key player in the bodys immune response to chronic stress
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
5. Merck & Co., Inc. Response to Todays New York Medicaid Suit
6. Maternal depression and controlling behavior associated with increased stress response in infants
7. Family history of alcoholism affects response to drug used to treat heavy drinking
8. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
9. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
10. PET scans can accurately detect a breast tumors response to chemotherapy
11. DNA damage response confers a barrier for viral tumorigenesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...versity of Pennsylvania report the first ever use ... multiple body organs.// Mucopolysaccharidosis VII... called lysosomal storage diseases. Other examples...PS involves an enzyme defect, leading to blindness...
...e new high-tech abortion drug being freely sold ov...f do-it-yourself-abortions,// experts fear. Alread...tives, they claim, and even as the pharmaceutical ...ar meals ostensibly to introduce them to “the revo...
...gh discovery, American researchers have found some...pond to stimuli in the womb. There have always bee...mens such as 'hothousing',// where the baby is rea...he womb. However, the effectiveness of inventions...
...emical Laboratory (NCL) and Emcure Pharmaceuticals...ith a new drug for the treatment of hypertension. ...sday,// NCL director Sivaram and Emcure managing d...odipine, a product of their collaborative research...
Other Medicine News:Health News:Abortion made easy pill causes alarm in state 2
(Date:10/9/2008)...ocuses on the need to protect the eyesight of,olde... 45 million people worldwide who,are blind, 80 per...ould,have avoided their blindness if they had been...imedia News Release, go to:, http://www.prnewswire... in eye care products and equipment, is,partnering...
(Date:10/9/2008)...- Diamyd Medical reports,th...he New England Journal,of Medicine, has published ...f the Diamyd(R) diabetes vaccine for type 1 diabet...20080314/297194 ), The article is now available ...and will be in print on October 30. It presents th...
(Date:10/8/2008)...e Pioneers Research That May Offer New Hope to,Hea... -- Nationally, over 3,000 people are,waiting for ...y, only half,of those will receive a transplant. N... (AHI) is paving the way for how to treat congesti...timedia News Release, go to:, http://www.prnewswir...
(Date:10/8/2008)... Potency of Poly-ICR as Vaccine Adjuvant, SAN DIE...rmaceuticals,Corporation (TSX: NVN) today presente... proprietary Toll-like Receptor 3 agonist, Poly IC...ngress 2008 in Lyon, France.,Study results demonst...geting the Toll-like Receptor 3 (TLR3) pathway. Da...
Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 1Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 2Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 3Survival data presented from phase II study of hormone resistant prostate cancer patients 1991 1Survival data presented from phase II study of hormone resistant prostate cancer patients 1991 2Genes and environment grant funds close look at nature nurture overlap in common diseases 558 1Genes and environment grant funds close look at nature nurture overlap in common diseases 558 2Genes and environment grant funds close look at nature nurture overlap in common diseases 558 3New use for stem cells found in war on terrorism 556 1New use for stem cells found in war on terrorism 556 2New use for stem cells found in war on terrorism 556 3
0.5 mm, 1 x 2 teeth set at 45 degrees and 6 mm tying platform. Serrated handle with polished finish.
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees.
Colibri style tips with 0.12 mm, 1 x 2 teeth. Round knurled handle with alignment pin and polished finish.
0.12 mm, 1 x 2 teeth set at 45 degrees with 6 mm tying platform. Wide serrated handle with polished finish.
Medicine Products: